These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21931020)

  • 1. Flushing oral oncology drugs down the toilet.
    Ratain MJ
    J Clin Oncol; 2011 Oct; 29(30):3958-9. PubMed ID: 21931020
    [No Abstract]   [Full Text] [Related]  

  • 2. Food and oral antineoplastics: more than meets the eye.
    Jain RK; Brar SS; Lesko LJ
    Clin Cancer Res; 2010 Sep; 16(17):4305-7. PubMed ID: 20736331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology products.
    Kang SP; Ratain MJ
    Clin Cancer Res; 2010 Sep; 16(17):4446-51. PubMed ID: 20736327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast and flawed or scientifically sound: the argument for administering oral oncology drugs during fasting.
    Todd M; Meyers ML; Charnas R; Acharya M; Molina A
    J Clin Oncol; 2012 Mar; 30(8):888-9; author reply 889. PubMed ID: 22331950
    [No Abstract]   [Full Text] [Related]  

  • 5. Importance of food effects for oral oncology drugs.
    Ratain MJ
    Clin Adv Hematol Oncol; 2012 Jun; 10(6):397-8. PubMed ID: 22895243
    [No Abstract]   [Full Text] [Related]  

  • 6. Monthly dosage form of leuprolide approved by FDA.
    Oncology (Williston Park); 1989 Apr; 3(4):139. PubMed ID: 2518158
    [No Abstract]   [Full Text] [Related]  

  • 7. The virtue of low-flow toilets.
    Needle MN
    J Clin Oncol; 2012 Mar; 30(8):890; author reply 890. PubMed ID: 22331942
    [No Abstract]   [Full Text] [Related]  

  • 8. Food Effect Studies for Oncology Drug Products.
    Parsad S; Ratain MJ
    Clin Pharmacol Ther; 2017 May; 101(5):606-612. PubMed ID: 28073144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revised physician labelling for neuroleptic drugs: Food and Drug Administration. Notice.
    Fed Regist; 1980 Aug; 45(155):52931-3. PubMed ID: 10314517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labeling Changes for Vinca Alkaloid Chemotherapies.
    Aschenbrenner DS
    Am J Nurs; 2021 May; 121(5):25. PubMed ID: 33872259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral chemotherapy food and drug interactions: a comprehensive review of the literature.
    Segal EM; Flood MR; Mancini RS; Whiteman RT; Friedt GA; Kramer AR; Hofstetter MA
    J Oncol Pract; 2014 Jul; 10(4):e255-68. PubMed ID: 24756141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity and metabolism of E-DES-diphosphate.
    Oelschläger H; Rothley D; Dunzendorfer U
    Prog Clin Biol Res; 1989; 303():187-95. PubMed ID: 2780647
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug safety labeling for doctors.
    Hecht A
    FDA Consum; 1979 Oct; 13(8):12-3. PubMed ID: 10309108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food Effect Study Design With Oral Drugs: Lessons Learned From Recently Approved Drugs in Oncology.
    Farha M; Masson E; Tomkinson H; Mugundu G
    J Clin Pharmacol; 2019 Apr; 59(4):463-471. PubMed ID: 30536979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To Take or Not to Take With Meals? Unraveling Issues Related to Food Effects Labeling for Oral Antineoplastic Drugs.
    Deng J; Brar SS; Lesko LJ
    Clin Pharmacol Drug Dev; 2018 Jun; 7(5):455-464. PubMed ID: 29197167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conflicting meal recommendations for oral oncology drugs: pose risks to patient care?
    Yu G; Wu DN; Gong Y; Li GF; Zhou HH
    Eur J Clin Pharmacol; 2018 Jun; 74(6):833-842. PubMed ID: 29536134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral antineoplastic agents for prostate cancer].
    Kume H
    Nihon Rinsho; 2011 Jun; 69 Suppl 5():522-4. PubMed ID: 22208037
    [No Abstract]   [Full Text] [Related]  

  • 18. Food effects on oral agents.
    Lewis LD
    Clin Adv Hematol Oncol; 2007 Aug; 5(8):589-90. PubMed ID: 17982397
    [No Abstract]   [Full Text] [Related]  

  • 19. Degarelix (firmagon) for prostate cancer.
    Med Lett Drugs Ther; 2009 Oct; 51(1323):82-3. PubMed ID: 19838145
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of natural product interactions in oncology.
    Block KI
    Integr Cancer Ther; 2013 Jan; 12(1):4-6. PubMed ID: 23188923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.